Combined oral contraceptive with anti-androgenic activity

This page covers all Combined oral contraceptive with anti-androgenic activity drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Estrogen receptor, progesterone receptor, androgen receptor, Androgen receptor (cyproterone acetate); estrogen receptor (ethinyl estradiol); gonadotropin suppression.

Targets

Estrogen receptor, progesterone receptor, androgen receptor · Androgen receptor (cyproterone acetate); estrogen receptor (ethinyl estradiol); gonadotropin suppression

Marketed (2)

• ethinyl estradiol and cyproterone acetate · S.C.B. Medical College and Hospital · Contraception and Gynecology
  Ethinyl estradiol and cyproterone acetate is a combined oral contraceptive that suppresses ovulation through hormonal inhibition and reduces androgenic effects through anti-androgenic activity.
• Ethinyl Estradiol + Cyproterone acetate · Fundação Educacional Serra dos Órgãos · Endocrinology / Gynecology
  Ethinyl estradiol suppresses gonadotropins while cyproterone acetate blocks androgen receptors, reducing androgenic effects in women.

Patent intelligence

• combined oral contraceptive with anti androgenic activity patent landscape — aggregated cliff calendar, attackable patents, originator estates